Skip to main content
Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
17.08
+0.59 (3.58%)
At close: Apr 28, 2026, 4:00 PM EDT
17.08
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Nurix Therapeutics Revenue

Nurix Therapeutics had revenue of $6.25M in the quarter ending February 28, 2026, a decrease of -66.12%. This brings the company's revenue in the last twelve months to $71.78M, up 27.23% year-over-year. In the fiscal year ending November 30, 2025, Nurix Therapeutics had annual revenue of $83.98M with 53.95% growth.

Revenue (ttm)
$71.78M
Revenue Growth
+27.23%
P/S Ratio
25.14
Revenue / Employee
$226,432
Employees
317
Market Cap
1.77B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Nov 30, 202583.98M29.43M53.95%
Nov 30, 202454.55M-22.44M-29.15%
Nov 30, 202376.99M38.36M99.31%
Nov 30, 202238.63M8.88M29.84%
Nov 30, 202129.75M11.93M66.95%
Nov 30, 2020 Pro Pro Pro
Nov 30, 2019 Pro Pro Pro
Nov 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harmony Biosciences Holdings 868.45M
Innoviva 411.33M
Vericel 276.26M
AnaptysBio 234.60M
Vir Biotechnology 68.56M
Nuvation Bio 62.90M
Generate Biomedicines 31.89M
AtaiBeckley 4.09M
Revenue Rankings

NRIX News

More News